On June 12, 2013, the first subject was enrolled in our new study of MDMA-assisted psychotherapy for PTSD taking place in Boulder, Colorado. Led by Principal Investigator Marcela Ot’alora, this study is exploring the safety and effectiveness of MDMA-assisted psychotherapy for 12 subjects with chronic, treatment-resistant PTSD due to sexual assault, military combat, or other causes. This study is also investigating whether pairing intern psychotherapists with experienced co-therapists can be effective, help reduce the cost of treatment, and train the next generation of MDMA therapists. On May 21, the MDMA for the study arrived at the study pharmacy, and on June 7 it was compounded, encapsulated, packaged, and labeled in preparation for the study. We are continuing to screen subjects, and expect to treat the first subject in early July.
